Chugai Pharmaceutical Co., Ltd.
$46.08▲ 6.14%(+$2.67)
TickerSpark Score
72/100
▌ Solid
60
Valuation
100
Profitability
70
Growth
100
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHGCF research report →
52-Week Range24% of range
Low
$39.03
Current
$46.08
High
$68.08
Company Overviewwww.chugai-pharm.co.jp
About the company
Chugai Pharmaceutical Co. , Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals.
- CEO
- Osamu Okuda
- IPO
- 2012
- Employees
- 5,104
- HQ
- Chuo, BC, JP
Price Chart
-11.16% · this period
Valuation
- Market Cap
- $75.83B
- P/E
- 27.81
- P/S
- 9.74
- P/B
- 6.59
- EV/EBITDA
- 18.33
- Div Yield
- 2.79%
Profitability
- Gross Margin
- 71.45%
- Op Margin
- 47.55%
- Net Margin
- 35.02%
- ROE
- 23.16%
- ROIC
- 23.03%
Growth & Income
- Revenue
- $1.26T · 7.55%
- Net Income
- $434.39B · 12.15%
- EPS
- $263.96 · 12.16%
- Op Income
- $590.71B
- FCF YoY
- -20.18%
Performance & Tape
- 52W High
- $68.08
- 52W Low
- $39.03
- 50D MA
- $48.78
- 200D MA
- $52.26
- Beta
- 0.56
- Avg Volume
- 8.90K
Get TickerSpark's AI analysis on CHGCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · CHGCF
Our CHGCF coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on CHGCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CHGCF report →Internal Compare
Similar companies
Peers in the same neighborhood.